 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hormone/growth factor
|
PDB id
|
|
|
|
1zkz
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/growth factor
|
 |
|
Title:
|
 |
Crystal structure of bmp9
|
|
Structure:
|
 |
Growth/differentiation factor 2. Chain: a. Fragment: growth/differentiation factor 2, residues 320-429 synonym: gdf-2, bone morphogenetic protein 9, bmp-9. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: gdf2, bmp9. Expressed in: cricetulus griseus. Expression_system_taxid: 10029. Expression_system_tissue: ovary cells.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.33Å
|
R-factor:
|
0.233
|
R-free:
|
0.272
|
|
|
Authors:
|
 |
M.A.Brown,Q.Zhao,K.A.Baker,C.Naik,C.Chen,L.Pukac,M.Singh,T.T Y.Parice,A.Mahoney,V.Roschke,I.Sanyal,S.Choe
|
Key ref:
|
 |
M.A.Brown
et al.
(2005).
Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
J Biol Chem,
280,
25111-25118.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
04-May-05
|
Release date:
|
24-May-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q9UK05
(GDF2_HUMAN) -
Growth/differentiation factor 2
|
|
|
|
Seq: Struc:
|
 |
 |
 |
429 a.a.
107 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biochemical function
|
growth factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
280:25111-25118
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of BMP-9 and functional interactions with pro-region and receptors.
|
|
M.A.Brown,
Q.Zhao,
K.A.Baker,
C.Naik,
C.Chen,
L.Pukac,
M.Singh,
T.Tsareva,
Y.Parice,
A.Mahoney,
V.Roschke,
I.Sanyal,
S.Choe.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Bone morphogenetic proteins (BMPs), a subset of the transforming growth factor
(TGF)-beta superfamily, regulate a diverse array of cellular functions during
development and in the adult. BMP-9 (also known as growth and differentiation
factor (GDF)-2) potently induces osteogenesis and chondrogenesis, has been
implicated in the differentiation of cholinergic neurons, and may help regulate
glucose metabolism. We have determined the structure of BMP-9 to 2.3 A and
examined the differences between our model and existing crystal structures of
other BMPs, both in isolation and in complex with their receptors. TGF-beta
ligands are translated as precursors, with pro-regions that generally dissociate
after cleavage from the ligand, but in some cases (including GDF-8 and
TGF-beta1, -2, and -3), the pro-region remains associated after secretion from
the cell and inhibits binding of the ligand to its receptor. Although the
proregion of BMP-9 remains tightly associated after secretion, we find, in
several cell-based assays, that the activities of BMP-9 and BMP-9.pro-region
complex were equivalent. Activin receptor-like kinase 1 (ALK-1), an orphan
receptor in the TGF-beta family, was also identified as a potential receptor for
BMP-9 based on surface plasmon resonance studies (BIAcore) and the ability of
soluble ALK-1 to block the activity of BMP-9.pro-region complex in cell-based
assays.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Structure of BMP-9. A, Ribbon diagram of BMP-9,
showing finger regions 1 and 2 (F1 and F2) and -helix 3
( 3). The pre-helix loop,
which likely encodes specificity determinants, is colored red.
C, C terminus; N, N terminus. B, overlay of BMP-9 (blue) and
BMP-2 (pink) with BMPR-IA ectodomain. Residues of BMPR-IA within
4.0 Å of BMP-2 are shaded green (36). The
carboxyl-terminal residue of BMPR-IA ectodomain is shaded
yellow. C, overlay of BMP-9 (blue) and BMP-7 (green) with
ActR-II ectodomain. Residues of ActR-II within 4.0 Å of
BMP-2 are shaded red (28). The carboxyl-terminal residues of
ActR-II ectodomain are shaded yellow. B and C were produced with
DINO software (www.dino3d.org).
|
 |
Figure 2.
FIG. 2. Sequence alignment of BMP-9, BMP-2, BMP-7, BMP-6,
and GDF-8. Pro-regions are boxed and shaded gray, furin cleavage
sites at the end of each pro-region are boxed in blue. Regions
of type II receptor binding are boxed and shaded green (28),
regions of type I receptor binding are boxed and shaded purple
(27), and conserved cysteines are shaded yellow. Profiles of
structural similarity determined by STAMP (34) are boxed in
gray. Amino-terminal signal sequences of each protein were
omitted from the alignment. Ligands and pro-regions were aligned
separately with ClustalW (35).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
25111-25118)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.C.Schnitzler,
T.J.Mellott,
I.Lopez-Coviella,
Y.N.Tallini,
M.I.Kotlikoff,
M.T.Follettie,
and
J.K.Blusztajn
(2010).
BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons.
|
| |
J Neurosci, 30,
8221-8228.
|
 |
|
|
|
|
 |
C.C.Rider,
and
B.Mulloy
(2010).
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists.
|
| |
Biochem J, 429,
1.
|
 |
|
|
|
|
 |
J.W.Lowery,
and
M.P.de Caestecker
(2010).
BMP signaling in vascular development and disease.
|
| |
Cytokine Growth Factor Rev, 21,
287-298.
|
 |
|
|
|
|
 |
K.Miyazono,
Y.Kamiya,
and
M.Morikawa
(2010).
Bone morphogenetic protein receptors and signal transduction.
|
| |
J Biochem, 147,
35-51.
|
 |
|
|
|
|
 |
A.Hauburger,
S.von Einem,
G.K.Schwaerzer,
A.Buttstedt,
M.Zebisch,
M.Schräml,
P.Hortschansky,
P.Knaus,
and
E.Schwarz
(2009).
The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding.
|
| |
FEBS J, 276,
6386-6398.
|
 |
|
|
|
|
 |
B.Herrera,
M.van Dinther,
P.Ten Dijke,
and
G.J.Inman
(2009).
Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
|
| |
Cancer Res, 69,
9254-9262.
|
 |
|
|
|
|
 |
F.Chaverneff,
and
J.Barrett
(2009).
Casein kinase II contributes to the synergistic effects of BMP7 and BDNF on Smad 1/5/8 phosphorylation in septal neurons under hypoglycemic stress.
|
| |
J Neurochem, 109,
733-743.
|
 |
|
|
|
|
 |
H.Senta,
H.Park,
E.Bergeron,
O.Drevelle,
D.Fong,
E.Leblanc,
F.Cabana,
S.Roux,
G.Grenier,
and
N.Faucheux
(2009).
Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations.
|
| |
Cytokine Growth Factor Rev, 20,
213-222.
|
 |
|
|
|
|
 |
J.Nickel,
W.Sebald,
J.C.Groppe,
and
T.D.Mueller
(2009).
Intricacies of BMP receptor assembly.
|
| |
Cytokine Growth Factor Rev, 20,
367-377.
|
 |
|
|
|
|
 |
K.L.Walton,
Y.Makanji,
M.C.Wilce,
K.L.Chan,
D.M.Robertson,
and
C.A.Harrison
(2009).
A common biosynthetic pathway governs the dimerization and secretion of inhibin and related transforming growth factor beta (TGFbeta) ligands.
|
| |
J Biol Chem, 284,
9311-9320.
|
 |
|
|
|
|
 |
L.David,
J.J.Feige,
and
S.Bailly
(2009).
Emerging role of bone morphogenetic proteins in angiogenesis.
|
| |
Cytokine Growth Factor Rev, 20,
203-212.
|
 |
|
|
|
|
 |
M.H.Alaoui-Ismaili,
and
D.Falb
(2009).
Design of second generation therapeutic recombinant bone morphogenetic proteins.
|
| |
Cytokine Growth Factor Rev, 20,
501-507.
|
 |
|
|
|
|
 |
D.Sheyn,
N.Kimelman-Bleich,
G.Pelled,
Y.Zilberman,
D.Gazit,
and
Z.Gazit
(2008).
Ultrasound-based nonviral gene delivery induces bone formation in vivo.
|
| |
Gene Ther, 15,
257-266.
|
 |
|
|
|
|
 |
G.Sengle,
N.L.Charbonneau,
R.N.Ono,
T.Sasaki,
J.Alvarez,
D.R.Keene,
H.P.Bächinger,
and
L.Y.Sakai
(2008).
Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
|
| |
J Biol Chem, 283,
13874-13888.
|
 |
|
|
|
|
 |
G.Sengle,
R.N.Ono,
K.M.Lyons,
H.P.Bächinger,
and
L.Y.Sakai
(2008).
A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7.
|
| |
J Mol Biol, 381,
1025-1039.
|
 |
|
|
|
|
 |
M.E.Marquis,
E.Lord,
E.Bergeron,
L.Bourgoin,
and
N.Faucheux
(2008).
Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9.
|
| |
Biomaterials, 29,
1005-1016.
|
 |
|
|
|
|
 |
P.C.Bessa,
M.Casal,
and
R.L.Reis
(2008).
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts).
|
| |
J Tissue Eng Regen Med, 2,
1.
|
 |
|
|
|
|
 |
D.Liu,
J.Wang,
B.Kinzel,
M.Müeller,
X.Mao,
R.Valdez,
Y.Liu,
and
E.Li
(2007).
Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity.
|
| |
Blood, 110,
1502-1510.
|
 |
|
|
|
|
 |
K.Pardali,
and
A.Moustakas
(2007).
Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
|
| |
Biochim Biophys Acta, 1775,
21-62.
|
 |
|
|
|
|
 |
L.Umans,
L.Cox,
M.Tjwa,
V.Bito,
L.Vermeire,
K.Laperre,
K.Sipido,
L.Moons,
D.Huylebroeck,
and
A.Zwijsen
(2007).
Inactivation of Smad5 in endothelial cells and smooth muscle cells demonstrates that Smad5 is required for cardiac homeostasis.
|
| |
Am J Pathol, 170,
1460-1472.
|
 |
|
|
|
|
 |
X.Dong,
Q.Wang,
T.Wu,
and
H.Pan
(2007).
Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface.
|
| |
Biophys J, 93,
750-759.
|
 |
|
|
|
|
 |
A.E.Harrington,
S.A.Morris-Triggs,
B.T.Ruotolo,
C.V.Robinson,
S.Ohnuma,
and
M.Hyvönen
(2006).
Structural basis for the inhibition of activin signalling by follistatin.
|
| |
EMBO J, 25,
1035-1045.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Lux,
F.Salway,
H.K.Dressman,
G.Kröner-Lux,
M.Hafner,
P.J.Day,
D.A.Marchuk,
and
J.Garland
(2006).
ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression.
|
| |
BMC Cardiovasc Disord, 6,
13.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2006).
Survey of the year 2005 commercial optical biosensor literature.
|
| |
J Mol Recognit, 19,
478-534.
|
 |
|
|
|
|
 |
V.Rosen
(2006).
BMP and BMP inhibitors in bone.
|
| |
Ann N Y Acad Sci, 1068,
19-25.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|